NCT01726270 - An 8-week, Open-label, Uncontrolled Study of Tamsulosin 0.4mg in Men With Bothersome Urinary Symptoms | Biotech Hunter

Enrollment

689

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

March 31, 2013

Study Completion Date

March 31, 2013

Conditions

Lower Urinary Tract Symptoms

Interventions

DRUG

tamsulosin

0.4 mg

Trial Locations (18)

Boehringer Ingelheim Investigational Site, Hoover

Boehringer Ingelheim Investigational Site, Mesa

Boehringer Ingelheim Investigational Site, Encino

Boehringer Ingelheim Investigational Site, Garden Grove

Boehringer Ingelheim Investigational Site, La Habra

Boehringer Ingelheim Investigational Site, Anoka

Boehringer Ingelheim Investigational Site, Elk River

Boehringer Ingelheim Investigational Site, Fridley

Boehringer Ingelheim Investigational Site, Roseville

Boehringer Ingelheim Investigational Site, Saint Francis

Boehringer Ingelheim Investigational Site, Albuquerque

Boehringer Ingelheim Investigational Site, Longview

Boehringer Ingelheim Investigational Site, Tyler

Boehringer Ingelheim Investigational Site, Bountiful

Boehringer Ingelheim Investigational Site, Layton

Boehringer Ingelheim Investigational Site, Salt Lake City

Boehringer Ingelheim Investigational Site, Syracuse

Boehringer Ingelheim Investigational Site, Richmond